Although available data suggest that irisin can be a possible substance for the regression of cancer by decreasing pro-inflammatory markers linked to obesity, there are still a few controversies regarding the benefits of irisin, as some studies show no effect of irisin on various cancers [69]. The gene discussed is FNDC5; the disease is obesity disorder.